| CTRI Number |
CTRI/2026/01/100240 [Registered on: 02/01/2026] Trial Registered Prospectively |
| Last Modified On: |
07/03/2026 |
| Post Graduate Thesis |
Yes |
| Type of Trial |
Interventional |
|
Type of Study
|
Surgical/Anesthesia |
| Study Design |
Randomized, Parallel Group Trial |
|
Public Title of Study
|
Comparison Of Analgesic Efficacy Of Nebulized Dexmedetomidine And Lignocaine On Post-Operative Pain in tonsillectomy Under General Anaesthesia.
|
|
Scientific Title of Study
|
Comparison of analgesic efficacy of nebulized dexmedetomidine and lignocaine on post-operative pain in pediatric tonsillectomy under |
| Trial Acronym |
CAENDL-PPT |
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NIL |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Surbhi Kataria |
| Designation |
DNB resident , department of anesthesiology |
| Affiliation |
BPS GMC khanpur kalan , sonepat |
| Address |
DEPARTMENT OF ANAESTHESIOLOGY,BPS GMC KHANPUR KALAN SONIPAT DEPARTMENT OF ANAESTHESIOLOGY , BPS GMC KHANPUR KALAN SONIPAT Sonipat HARYANA 131505 India |
| Phone |
8076532728 |
| Fax |
|
| Email |
Katariasurbhii43@gmail.com |
|
Details of Contact Person Scientific Query
|
| Name |
DR KIRTI AHUJA |
| Designation |
PROFESSOR , MBBS , MD (ANAESTHESIA) |
| Affiliation |
BPS GMC KHANPUR KALAN SONIPAT |
| Address |
DEPARTMENT OF ANAESTHESIOLOGY,BPS GMC KHANPUR KALAN SONIPAT DEPARTMENT OF ANAESTHESIOLOGY,BPS GMC KHANPUR KALAN SONIPAT Sonipat HARYANA 131305 India |
| Phone |
9992111890 |
| Fax |
|
| Email |
kirtiahuja2812@gmail.com |
|
Details of Contact Person Public Query
|
| Name |
DR PRATEEK |
| Designation |
ASSISTANT PROFESSOR , MBBS ,MD (ANAESTHESIA)D |
| Affiliation |
DEPARTMENT OF ANAESTHESIOLOGY,BPS GMC KHANPUR KALAN SONIPAT |
| Address |
DEPARTMENT OF ANAESTHESIOLOGY,BPS GMC KHANPUR KALAN SONIPAT DEPARTMENT OF ANAESTHESIOLOGY,BPS GMC KHANPUR KALAN SONIPAT Sonipat HARYANA 131305 India |
| Phone |
8683973839 |
| Fax |
|
| Email |
neopatricks@gmail.com |
|
|
Source of Monetary or Material Support
|
|
|
Primary Sponsor
|
| Name |
BPSGMC KHANPUR KALAN SONIPAT |
| Address |
BPSGMC KHANPUR KALAN SONIPAT |
| Type of Sponsor |
Government medical college |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| DR SURBHI KATARIA |
BPSGMC for Women KHANPUR KALAN SONIPAT |
BPSGMC for WOMEN KHANPUR KALAN SONIPAT HARYANA Sonipat HARYANA |
8076532728
katariasurbhii43@gmail.com |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| BPSGMC FOR WOMEN KHANPUR KALAN SONIPAT |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
(1) ICD-10 Condition: J039||Acute tonsillitis, unspecified, |
|
|
Intervention / Comparator Agent
|
| Type |
Name |
Details |
| Intervention |
DEXMEDETOMIDINE |
1. Nebulization with dexmedetomidine 2 µg/kg diluted upto 4 mL with normal saline 30 minutes before induction |
| Comparator Agent |
LIGNOCAINE |
Nebulization with lignocaine 4% solution, 4 mg/kg in 4ml normal saline 30 minutes prior to induction . |
| Intervention |
Nil |
Nil |
|
|
Inclusion Criteria
|
| Age From |
4.00 Year(s) |
| Age To |
12.00 Year(s) |
| Gender |
Both |
| Details |
1.Pediatric patients aged between 4 to 12 years
2.Scheduled for elective tonsillectomy under general anaesthesia.
2.ASA physical status I or II. |
|
| ExclusionCriteria |
| Details |
1.Patients with any congenital abnormality
2.Patients with upper respiratory tract infection and having known allergy to dexmedetomidine, lignocaine, or any other local anaesthetics.
3.History of any neurological disorders (e.g., cerebral palsy, epilepsy).
4.Severe systemic illnesses (e.g., cardiovascular, hepatic, or renal diseases).
5.Children with a history of previous airway surgery
6.Patients and /or his/her legally acceptable representative not willing to participate in the present study.
SAMPLE SIZE AND SAMPLING:
As per previously conducted study |
|
|
Method of Generating Random Sequence
|
Computer generated randomization |
|
Method of Concealment
|
Sequentially numbered, sealed, opaque envelopes |
|
Blinding/Masking
|
Participant and Investigator Blinded |
|
Primary Outcome
|
| Outcome |
TimePoints |
Duration of effective postperative analgesia (Time of first rescue analgesic and total analgesic doses in 24 hours)
|
Every 30 minutes |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
| Time to first oral intake |
|
| Emergence agitation score using PAED scale |
followed @ 5,10,15 and 30 min post-extubation |
| Sedation score |
@ 1 and 24 hours interval |
| Haemodynamic parameters |
Prenebulisation,postnebulisation,@induction ,every 5 minutes intraoperatively and post operatively @30 min.,1,2,4,6,12,24 hours interval |
| Incidence of side effects (bradycardia,hypotension,nausea,vomiting,respiratory depression) |
|
|
|
Target Sample Size
|
Total Sample Size="74" Sample Size from India="37"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
Phase 4 |
|
Date of First Enrollment (India)
|
12/01/2026 |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="1" Months="6" Days="0" |
|
Recruitment Status of Trial (Global)
|
Open to Recruitment |
| Recruitment Status of Trial (India) |
Open to Recruitment |
Publication Details
Modification(s)
|
will be published as thesis and research article as applicable |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - YES
- What data in particular will be shared?
Response - Individual participant data that underlie the results reported in this article, after de-identification (text, tables, figures, and appendices).
- What additional supporting information will be shared?
Response - Study Protocol Response - Informed Consent Form Response - Clinical Study Report
- Who will be able to view these files?
Response - Researchers whose proposed use of the data has been approved by an independent review committee identified for this purpose.
- For what types of analyses will this data be available?
Response - For individual participant data meta-analysis.
- By what mechanism will data be made available?
Response - Proposals should be directed to [Katariasurbhii43@gmail.com].
- For how long will this data be available start date provided 30-05-2028 and end date provided 12-10-2031?
Response - Beginning 9 months and ending 36 months following article publication.
- Any URL or additional information regarding plan/policy for sharing IPD?
Additional Information - NIL
|
Brief Summary
Modification(s)
|
This randomised, double-blind, controlled study will be conducted to compare the analgesic efficacy of nebulisation with Dexmedetomidine and Lignocaine on postoperative pain in pediatric patient posted for tonsillectomy under general anaesthesia. The primary objective will be to compare the duration of postoperative analgesia while secondary objective will be to compare the incidence and severity of emergence delirium, and compare the haemodynamic parameters preoperatively, intraoperatively and postoperatively between the groups , to assess and compare the sedation level using standardized sedation scale , to assess the level of anxiety by child separation score, to assess the incidence of adverse effects such as bradycardia, hypotension, respiratory depression ,nausea ,vomiting .The study will be carried out in Department of Anaesthesia OT complex & ENT ward at Bhagat Phool Singh Government Medical College , Khanpur Kalyan ,Sonepat , over a 18 month period, enrolling a total of 74 children aged 4 to 14 years undergoing tonsillectomy under general anaesthesia. Patients who meet the inclusion criteria (ASA physical status I or II) will be randomly allocated into two groups of 37 each. Group D (Dexmedetomidine) will receive nebulization with Dexmedetomidine 2mcg/kg diluted upto 4ml with normal saline 30 minutes before induction. Group L (Lignocaine) will receive nebulization with Lignocaine 4% solution,4mg/kg in 4ml normal saline 30minutes prior to induction. Randomisation will be done using computer-generated random numbers, and drug preparation will be performed by an anaesthesiologist not involved in outcome assessment. After pre-anaesthetic evaluation patient’s attendees will be counselled about the anaesthetic procedure and received in pre-operative room on the morning of surgery after confirming NPO status, recording of vitals parameters and IV line will be established and isolyte-P will be started using Holiday-Segar’s formula. Nebulization will be done by standard hospital portable nebuliser 15 minutes before induction.The baseline parameter like non-invasive blood pressure (NIBP) , electrocardiogram (ECG) , pulse rate , pulse oximetry (Spo2) , will be recorded before and after nebulization. Patient will be shifted to the operating room theatre, all vital ASA standard monitors will be attached such as heart rate, non-invasive blood pressure, electrocardiogram, oxygen saturation and respiratory rate will be recorded. Standard method of anaesthesia will be used while inducing the patient. Premedication will be with midazolam 0.05 mg/kg, glycopyrrolate 0.04 mg/kg , induction will be with fentanyl 1mcg, propofol 2-3mg/kg and atracurium 0.5 mg/kg. Airway will be secured with an appropriate- sized airway device once the jaw is sufficiently relaxed. Size of endotracheal tube will be according to age and weight of the patient. Maintainence of anaesthesia is with O2+N2O (50:50%) and titrated sevofluorane with pressure-controlled ventilation,0.12 mg/kg atracurium at fixed intervals and maintainence of Etco2 between 35-45 mmhg. Neuromuscular blockade will be reversed with standard doses of neostigmine 0.05mg/kg and glycopyrrolate 0.01 mg/kg. After extubation , in the post anaesthesia care unit , FPS-R scale revised scoring will be recorded postoperatively. Emergence agitation will be assessed by (PAED) Pediatric Anaesthesia Emergence Delirium score and sedation will be assessed by using Modified Ramsay Sedation score. Time for oral intake will be noted . Patient will be receiving i.v. Paracetamol 10 mg/kg as rescue analgesia if requested and the total consumption of postoperative rescue analgesia will be recorded. Inj Dexamethasone 0.1 mg/kg will be used as second rescue analgesic. |